Sign in to continue:

Wednesday, April 1st, 2026

Cartesian Growth Corporation II 2025 Annual Report: Business Strategy, Risk Factors, and Initial Business Combination Overview




Cartesian Growth Corporation II 2025 Annual Report: Key Highlights and Investor Implications

Cartesian Growth Corporation II 2025 Annual Report: Key Highlights and Investor Implications

Introduction

Cartesian Growth Corporation II (“the Company”) has released its Annual Report for the fiscal year ended December 31, 2025. This comprehensive financial report provides crucial updates on the status of the company, important events that have occurred during the fiscal year, risk factors, and strategic directions. This article summarizes the key points and assesses their implications for shareholders and potential investors.

Key Highlights

  • Company Structure: Cartesian Growth Corporation II is a blank check company incorporated in the Cayman Islands, formed to effect mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations with one or more businesses. The company particularly targets transnational businesses with high growth potential, leveraging the management team’s reputation and network.
  • Delisting from Nasdaq and Shift to OTC Market: The company’s securities were suspended from trading on Nasdaq on May 13, 2025, and officially delisted as of July 15, 2025. Following this, the company’s securities are now quoted on the OTC Pink Limited Market (“OTC”). Despite this, Cartesian Growth II remains a reporting entity under the Securities Exchange Act of 1934, continuing to disclose financial and operational information.
  • Extension and Amendments: On November 6, 2024, shareholders approved amendments to the company’s memorandum and articles of association, including the removal of the restriction that prevented redemption of Class A ordinary shares if it would result in net tangible assets falling below \$5,000,001. This change provides greater flexibility in the redemption process and business combination structuring.
  • Business Combination Deadline: The company has until the “Extended Date” (not specified in the excerpt) to consummate an initial business combination. If a combination is not completed by then, the company will cease operations, redeem public shares, and liquidate.
  • Reporting and Financial Statement Requirements: Cartesian Growth II is required to file annual, quarterly, and current reports with the SEC. Shareholders will receive audited financial statements of any prospective target business before a business combination.
  • Risk Factors: The report identifies numerous risks, including the company’s lack of operating history, the delisting from Nasdaq, challenges in completing a business combination, dependency on management, limited available capital, and the possibility that shareholders may receive less than \$10.30 per share on liquidation.
  • Shareholder Redemptions and PIPE Transactions: The company may issue shares in private placement (“PIPE”) transactions at prices approximating the trust account value per share, which may be below prevailing market prices. High redemption rates may limit the company’s ability to meet minimum cash conditions for a business combination, making such deals more difficult.
  • Management and Affiliate Involvement: The sponsor, officers, and directors have waived their redemption rights for founder shares and may have a conflict of interest when assessing business combinations. The company is not prohibited from pursuing a business combination with an affiliate but would require an independent fairness opinion in such cases.
  • Ongoing Risks: The company’s auditor has expressed substantial doubt about its ability to continue as a going concern. Other risks include limited working capital, dependence on loans from the sponsor or affiliates, and the uncertainty of market development for its securities.

Shareholder-Relevant and Price-Sensitive Issues

  • Delisting from Nasdaq: The shift to OTC Pink is a significant downgrade in listing standards and may limit liquidity, visibility, and institutional investor participation. This is a major red flag for shareholders and could negatively impact the share price.
  • Redemption and Liquidation Risks: If no business combination is achieved by the Extended Date, shareholders risk receiving only the trust account value (approximately \$10.30 per share or less) and warrants expiring worthless.
  • Ongoing Reporting Status: Although the company continues to file reports with the SEC, the lack of a major exchange listing increases operational and financing risks.
  • Removal of Redemption Limitation: The elimination of the net tangible asset redemption floor may allow the company to proceed with a business combination under circumstances that previously would not have been allowed, potentially increasing the risk for remaining shareholders.
  • Going Concern Warning: The existence of a going concern warning from the auditors underscores the financial fragility of the company and may affect investor confidence.
  • PIPE Transactions Below Market Value: Any private placements at or below trust value could dilute existing shareholders and exert downward pressure on the share price.

Detailed Investor Analysis

Business Outlook and Strategy: Cartesian Growth II remains focused on transnational businesses, aiming to leverage the management team’s experience post-combination. The company sets criteria for targets, seeking those with significant transnational operations, responsible investment alignment, established management, and willingness for enhanced governance. However, the pool of suitable targets is limited by the need for PCAOB-audited financials and compliance with U.S. reporting rules.

Financial Position and Capital Structure: The company’s financial viability is at risk due to its delisting, ongoing search for a target, and the need for additional financing. If funds outside the trust account are insufficient, the company will depend on loans from sponsors or affiliates, who are not obligated to provide such funding.

Risks and Uncertainties: The company faces notable operational risks, including the possibility of failing to complete a business combination, loss of capital, dilution through PIPE transactions, and the potential for negative market sentiment following its Nasdaq delisting. Additionally, macroeconomic risks (such as pandemics or geopolitical instability) could impact the company’s ability to identify and consummate a suitable business combination.

Conclusion

The 2025 Annual Report for Cartesian Growth Corporation II contains several material developments that are highly relevant for investors and could move the share price. Most notably, the delisting from Nasdaq, the continuing risk of liquidation, and the company’s ongoing struggle to secure a business combination all raise significant concerns about the company’s long-term viability and the value of its shares and warrants. Investors should closely monitor ongoing developments and consider the substantial risks before making investment decisions.


Disclaimer: The above article is a summary and analysis based on Cartesian Growth Corporation II’s 2025 Annual Report. It is intended for informational purposes only and does not constitute investment advice. Investors should consult their financial advisors and review the complete official filings before making investment decisions. The author and publisher do not assume any responsibility for investment outcomes resulting from reliance on this analysis.




View Cartesian Growth Corp II Historical chart here



   Ad